Literature DB >> 27838724

Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.

Jerry H Gurwitz1, Alan S Go2, Stephen P Fortmann3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27838724      PMCID： PMC5429025          DOI： 10.1001/jama.2016.15212

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.

Authors:  Michelle C Odden; Mark J Pletcher; Pamela G Coxson; Divya Thekkethala; David Guzman; David Heller; Lee Goldman; Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2015-04-21       Impact factor: 25.391

3.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

4.  Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Authors:  Robert J Glynn; Wolfgang Koenig; Børge G Nordestgaard; James Shepherd; Paul M Ridker
Journal:  Ann Intern Med       Date:  2010-04-20       Impact factor: 25.391

Review 5.  Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Brian R Ott; Lori A Daiello; Issa J Dahabreh; Beth A Springate; Kimberly Bixby; Manjari Murali; Thomas A Trikalinos
Journal:  J Gen Intern Med       Date:  2015-01-10       Impact factor: 5.128

6.  Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.

Authors:  Matthew K Ito; Kevin C Maki; Eliot A Brinton; Jerome D Cohen; Terry A Jacobson
Journal:  J Clin Lipidol       Date:  2013-11-09       Impact factor: 4.766

Review 7.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

8.  Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Authors:  Elizabeth D Kantor; Colin D Rehm; Jennifer S Haas; Andrew T Chan; Edward L Giovannucci
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

9.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Jackie Bosch; Gilles Dagenais; Jun Zhu; Denis Xavier; Lisheng Liu; Prem Pais; Patricio López-Jaramillo; Lawrence A Leiter; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Alexander Parkhomenko; Katalin Keltai; Matyas Keltai; Karen Sliwa; Ron J G Peters; Claes Held; Irina Chazova; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Gregorio Sanchez-Vallejo; Robert McKelvie; Janice Pogue; Hyejung Jung; Peggy Gao; Rafael Diaz; Eva Lonn
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245
  9 in total
  20 in total

1.  Availability and readability of patient education materials for deprescribing: An environmental scan.

Authors:  Michael Anthony Fajardo; Kristie Rebecca Weir; Carissa Bonner; Danijela Gnjidic; Jesse Jansen
Journal:  Br J Clin Pharmacol       Date:  2019-05-07       Impact factor: 4.335

Review 2.  Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines.

Authors:  Chelsea E Hawley; John Roefaro; Daniel E Forman; Ariela R Orkaby
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

3.  Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.

Authors:  Karen Krüger; Niklas Leppkes; Sabine Gehrke-Beck; Wolfram Herrmann; Engi A Algharably; Reinhold Kreutz; Christoph Heintze; Iris Filler
Journal:  Br J Gen Pract       Date:  2018-04-23       Impact factor: 5.386

4.  The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis.

Authors:  Zhen Zhou; Loai Albarqouni; Andrea J Curtis; Monique Breslin; Mark Nelson
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

5.  Research Priorities to Advance the Health and Health Care of Older Adults with Multiple Chronic Conditions.

Authors:  Mayra Tisminetzky; Elizabeth A Bayliss; Jay S Magaziner; Heather G Allore; Kathryn Anzuoni; Cynthia M Boyd; Thomas M Gill; Alan S Go; Susan L Greenspan; Leah R Hanson; Mark C Hornbrook; Dalane W Kitzman; Eric B Larson; Mary D Naylor; Benjamin E Shirley; Ming Tai-Seale; Linda Teri; Mary E Tinetti; Heather E Whitson; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2017-05-26       Impact factor: 5.562

Review 6.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

7.  Pravastatin for Primary Prevention in Older Adults: Restricted Mean Survival Time Analysis.

Authors:  Ariela R Orkaby; Michael W Rich; Ryan Sun; Eliah Lux; Lee-Jen Wei; Dae Hyun Kim
Journal:  J Am Geriatr Soc       Date:  2018-09-25       Impact factor: 5.562

8.  Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort.

Authors:  Kari Luotola; Satu Jyväkorpi; Annele Urtamo; Kaisu H Pitkälä; Mika Kivimäki; Timo E Strandberg
Journal:  Age Ageing       Date:  2020-02-27       Impact factor: 10.668

9.  Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.

Authors:  Kamal Awad; Maged Mohammed; Mahmoud Mohamed Zaki; Abdelrahman I Abushouk; Gregory Y H Lip; Michael J Blaha; Carl J Lavie; Peter P Toth; J Wouter Jukema; Naveed Sattar; Maciej Banach
Journal:  BMC Med       Date:  2021-06-22       Impact factor: 8.775

10.  Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials.

Authors:  Zhen Zhou; Loai Albarqouni; Monique Breslin; Andrea J Curtis; Mark Nelson
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.